Nadja Kopp

Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry

Alessandro Pastore, Vindi Jurinović, Robert Kridel et al. · The Lancet Oncology · 2015 · 613 citations

Medicine, Immunology, Oncology +17

A targeted mutational landscape of angioimmunoblastic T-cell lymphoma

Oreofe O. Odejide, Oliver Weigert, Andrew A. Lane et al. · Blood · 2013 · 429 citations · Full text

Medicine, Hematology, Oncology +11

BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia

Christopher J. Ott, Nadja Kopp, Liat Bird et al. · Blood · 2012 · 369 citations · Full text

Medicine, Immunology, Oncology +11

The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice

Elizabeth C. Townsend, Mark A. Murakami, Alexandra Christodoulou et al. · Cancer Cell · 2016 · 304 citations · Full text

Medicine, Biomedical Sciences, Drug Discovery +6

Genetic resistance to JAK2 enzymatic inhibitors is overcome by HSP90 inhibition

Oliver Weigert, Andrew A. Lane, Liat Bird et al. · The Journal of Experimental Medicine · 2012 · 162 citations · Full text

Medicine, Oncology, Pharmacology +14